Dynamic analysis of drug-induced cytotoxicity using chip-based dielectrophoretic cell immobilization technology

Khoshmanesh, K., Akagi, J., Nahavandi, S., Skommer, J., Baratchi, S., Cooper, J.M. , Kalantar-Zadeh, K., Williams, D.E. and Wlodkowic, D. (2011) Dynamic analysis of drug-induced cytotoxicity using chip-based dielectrophoretic cell immobilization technology. Analytical Chemistry, 83(6), pp. 2133-2144. (doi:10.1021/ac1029456)

Full text not currently available from Enlighten.

Abstract

Quantification of programmed and accidental cell death provides useful end-points for the anticancer drug efficacy assessment. Cell death is, however, a stochastic process. Therefore, the opportunity to dynamically quantify individual cellular states is advantageous over the commonly employed static, end-point assays. In this work, we describe the development and application of a microfabricated, dielectrophoretic (DEP) cell immobilization platform for the real-time analysis of cancer drug-induced cytotoxicity. Microelectrode arrays were designed to generate weak electro-thermal vortices that support efficient drug mixing and rapid cell immobilization at the delta-shape regions of strong electric field formed between the opposite microelectrodes. We applied this technology to the dynamic analysis of hematopoietic tumor cells that represent a particular challenge for real-time imaging due to their dislodgement during image acquisition. The present study was designed to provide a comprehensive mechanistic rationale for accelerated cell-based assays on DEP chips using real-time labeling with cell permeability markers. In this context, we provide data on the complex behavior of viable vs dying cells in the DEP fields and probe the effects of DEP fields upon cell responses to anticancer drugs and overall bioassay performance. Results indicate that simple DEP cell immobilization technology can be readily applied for the dynamic analysis of investigational drugs in hematopoietic cancer cells. This ability is of particular importance in studying the outcome of patient derived cancer cells, when exposed to therapeutic drugs, as these cells are often rare and difficult to collect, purify and immobilize.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Wlodkowic, Dr Donald and Cooper, Professor Jonathan
Authors: Khoshmanesh, K., Akagi, J., Nahavandi, S., Skommer, J., Baratchi, S., Cooper, J.M., Kalantar-Zadeh, K., Williams, D.E., and Wlodkowic, D.
College/School:College of Science and Engineering > School of Engineering > Biomedical Engineering
College of Science and Engineering > School of Engineering > Electronics and Nanoscale Engineering
Journal Name:Analytical Chemistry
ISSN:0003-2700
Published Online:23 February 2011

University Staff: Request a correction | Enlighten Editors: Update this record